Upload
phungkien
View
234
Download
3
Embed Size (px)
Citation preview
1
Teva introduction Teva introduction
2014
2
Our Vision
Being the most indispensable
medicines company for the world,
executing on our obligation to
our patients, customers,
shareholders and employees
We have Profound Foundations
45,000 employees
73 manufacturing
sites
111 years in
existence
1,000 molecules
60 countries
73B tablets and
capsules per annum
55,000+ SKUs
$5.01 2013 EPS
$20.3B 2013 revenues
Core Strengths
Leading healthcare provider
Balanced business
model
Integrated
R&D
Manufacturing strengths
Partnering experience
Go-to-market capabilities
Entrepreneurial employees and
culture
A truly global operations network
Financial Growth
* Operating income and net income are non-GAAP results
2013 2012
20,314 20,317 Sales $M
5,198 5,715 Operating Income $M
4,255 4,671 Net Income $M
Expansion of wealth and health care access
Rising health care costs
Our World Changes
Aging population
Increasing competition in generics
Shift in disease patterns
Rising bar for product innovation
Complicated, expanding global market
Branded generics business
R&D capabilities
Impact healthcare system
Pipeline of high-value products
Generics: a great future
Global
Sustainable high-barrier to entry
Rapid growth
Dramatically enhanced in selected areas
Research and development
Develop the most competitive
and focused pipeline
to address unmet patient needs
in a highly differentiated way
to drive the growth of Teva
Life and science intimately connected … that’s uniquely Teva
NTEs High value
generics
Focused specialty portfolio
NTEs - The Future of Teva R&D
NEW THERAPEUTIC ENTITY Known molecule that is formulated, delivered, or used in a novel way to
address specific patient needs
Specialty medicines: focus and build leadership
CNS
Respiratory
New Therapeutic Entities (NTEs)
Oncology, Women's Health, Biologics
Protect and expand MS franchise
Build products and pipeline
Invest in capabilities and pipeline
Continue global expansion
Capitalize on unique Teva interface
of Generics and Specialty
Selectively invest
17 17
OTC Business
World’s leading provider of medicines Portfolio of leading brands
Best-in-class
Consumer understanding
Brand-building
Advertising scale
Strong product development and
production capabilities World’s leading brand-
builder
+
PGT Consumer Healthcare: JV with P&G leverages value in existing OTC business
18
Teva Global Community Statement
Teva is committed to improving global healthcare. We recognize our responsibility to invest in and support the communities we serve.
We focus our involvement on the communities in the countries in which we operate, through a range of activities that enhance access to medicines and contribute to the wellbeing of the communities in which we live.
We are proud of our many employees who volunteer in the community and we support them in a range of ways.
19
20